{"id":"W2939222610","doi":"10.1056/nejmoa1811744","title":"Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5996,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; University of British Columbia","funders":"Janssen Research and Development","keywords":"Canagliflozin; Medicine; Type 2 diabetes; Diabetes mellitus; Diabetic nephropathy; Nephropathy; Dapagliflozin; Internal medicine; Clinical trial; Type 2 Diabetes Mellitus; Endocrinology; Intensive care medicine; Pharmacology; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004447189,0.000331039,0.0007716587,0.0005500432,0.0002547316,0.0007276186,0.0002851099,0.0005444384,0.001418912],"category_scores_gemma":[0.006037596,0.0001361586,0.0009023924,0.0006824404,0.0003238796,0.0003063698,0.0004689466,0.0009559304,0.00009222534],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005785925,"about_ca_system_score_gemma":0.0008026241,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001848481,"about_ca_topic_score_gemma":0.001911348,"domain_scores_codex":[0.998426,0.0008828568,0.0001050859,0.0001383784,0.0003064892,0.0001411908],"domain_scores_gemma":[0.9950258,0.002509757,0.001578728,0.0001338088,0.0002375776,0.0005142047],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.04456162,0.002416281,0.6693766,0.002618153,0.00769408,0.0002540881,0.0001699278,0.00281795,0.0004333348,0.001860128,0.005435664,0.2623622],"study_design_scores_gemma":[0.00596748,0.006876323,0.9616868,0.0009433383,0.005784635,0.0005753366,0.00008642861,0.004445757,0.0003264586,0.005691566,0.007566852,0.0000490024],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8046861,0.1767702,0.001283853,0.005351714,0.000806621,0.00009345334,0.0006199586,0.00003331139,0.01035475],"genre_scores_gemma":[0.9850255,0.01217434,0.0005051873,0.0007207626,0.0007765222,0.00005355009,0.0002570875,0.00000316605,0.0004838879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004447189,"threshold_uncertainty_score":0.02351928,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009162856530291195,"score_gpt":0.2442398749127619,"score_spread":0.2350770183824707,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}